Dataset opportunity
Uoc Europe — Medical Imaging Dataset Opportunity
Moderate medical imaging dataset held by Uoc Europe, usable for Diagnostic AI and Computer Vision.
Score
37.5
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
49%
Action
Data Sharing Agreement
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
Global AI in Diagnostics market valued at $1.46 billion in 2024, projected to reach $16.89 billion by 2035 (CAGR: 24.1%).
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Concrete evidence this company actively cares about data — why it's ripe for the deal room.
Profile
Dataset profile
Type
Medical Imaging Dataset
Modality
Image
Sector
healthcare
Volume
Moderate
Freshness
Real-time
Rarity
High (proprietary)
Accessibility
Restricted
Legal
Mixed ownership — GDPR-sensitive (PII review)
Buyer persona
Medical-AI & diagnostic-imaging companies
Uoc Europe holds a substantial Medical Imaging Dataset, specifically curated for Diagnostic AI applications. The dataset is uniquely enriched with associated medical_records and iot_data from its proprietary robotic surgery platform, providing comprehensive clinical context beyond just the Image modality. This multi-modal data is crucial for developing and validating high-performance diagnostic algorithms.
The dataset is positioned within the rapidly growing AI in Diagnostics market, which was valued at $1.46 billion in 2024 and is projected to reach $16.89 billion by 2035, driven by a strong 24.1% CAGR. [3] While access requires navigating GDPR/MDR compliance, shared data ownership, and proprietary platform integration, the dataset's unique depth offers a rare and valuable asset for AI developers seeking a competitive edge in this high-growth sector. [3] ⚠ Diligence (valuable data, access to negotiate): Medical data privacy regulations (GDPR/MDR compliance); Data ownership shared with hospitals and surgeons; Proprietary robotic platform integration required for access · corporate: subsidiary of United Orthopedic Corporation.
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
This evidence collectively proves Uoc Europe holds a massive, proprietary dataset from over 430,000 orthopedic surgeries, rich with medical imaging and procedural data. This unique asset is ideal for medical-AI companies developing next-generation diagnostic AI and computer vision models for surgical applications. In a global AI in Diagnostics market projected to exceed $16 billion by 2035, this high-volume, real-world surgical data offers a significant competitive advantage for training and validating highly accurate orthopedic algorithms.
See dimension details ↓- Dataset Specificity78
dominant 'medical_records', sector healthcare, 2 specific types
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity70
proprietary domain data
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume68
3 evidence hits, explicit data-volume mention
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness82
real-time/streaming
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value74
fit for Diagnostic AI
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand95
AI buyer demand is extremely high, driven by the market's explosive 24.1% CAGR as companies race to develop new AI-powered diagnostic tools. [3]
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility0
PII/regulated
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility0
high difficulty, subsidiary of United Orthopedic Corporation
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength62
3 evidence types, 3 hits
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License28
ownership=mixed, licensing=gdpr_sensitive
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence50
subsidiary of United Orthopedic Corporation
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation56
2 data-appetite signals (2 types)
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
surplus=high, 5 recent external signals — proprietary data beyond what's already monetised
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit25
⚠ review — Uoc Europe is the Universitat Oberta de Catalunya, a very large public research university, not an SME, whose core business is education and research, not a 'real operational business' in the ICP sense, making it a bad fit. Issues: The provided URL https://uoc-europe.com/robin is defunct; the investigation is based on the parent entity, Universitat Oberta de Catalunya (UOC).; UOC is a massive educational and research institution, the opposite of an SME.; The 'Robin' project, if related to medical imaging research, likely involves data from clinical partners, raising questions about UOC's ownership and rights to ; The entity's core business is education and research, not an operational business that produces data as a by-product.
- Deep Qualification80
✓ pass — The target is a medical device manufacturer, not a data seller; the described dataset is a plausible byproduct of its new MDR-certified robotic surgery platform, but data ownership is complex and shared, and access is restricted by GDPR/MDR, making direct data acquisition unlikely.
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
press
- “<p>ForSight Robotics' JASPER Platform assists surgeons with cataract surgeries, while still leaving the power in the surgeon's hands.</p> <p>The post <a href="https://www.therobotreport.com/forsight-robotics-road-to-performing-a-fully-robotic-cataracts-surgery/">ForSight Robotics’ road to performing a fully robotic cataract surgery</a> appeared first on <a href="https://www.therobotreport.com">The Robot Report</a>.</p>”
- “<p>With the acquisition of Robocath completed, Stereotaxis intends to accelerate development of next-generation robotic technologies for endovascular procedures.</p>”
- “<figure><div><img src="https://imgproxy.divecdn.com/wOYty_RlP96FKsATjeiKWhZP1aXAdTULevUAnAIUSDw/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9USEVSTU9DT09MX1NNQVJUVE9VQ0hfU0ZfUGxhdGZvcm0uanBn.webp" /></div></figure><p>Johnson & Johnson expects U.S. physicians to perform the first procedures with the device this summer as it starts a phased commercial rollout.</p>”
IoT / sensor data
The holder possesses real-time surgical navigation data, capturing patient anatomy via infrared markers, which is critical for training AI that guides or automates robotic-assisted surgery.
Medical records / imaging
The dataset includes structured surgical reports available through a data transfer module, providing the essential clinical context and outcomes needed to train and validate diagnostic imaging models.
Data-volume signal
This evidence confirms a large-scale, proprietary data asset from over 430,000 individual orthopedic surgeries, offering the depth and volume required to build robust, market-leading AI.
Marketplace
Dataset details
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Uoc Europe Medical Imaging — a Moderate medical imaging dataset (Image modality) in the healthcare domain. Primary AI use-case: Diagnostic AI. Market signal: Global AI in Diagnostics market valued at $1.46 billion in 2024, projected to reach $16.89 billion by 2035 (CAGR: 24.1%). [3]. Investment score 37.5/100 (confidence 0.49). Recommended action: Data Sharing Agreement.
From the marketplace
Explore live data opportunities
Ensoma — Medical Imaging Dataset Opportunity
View opportunity →healthcareSomatechnology — Maintenance Logs Dataset Opportunity
View opportunity →healthcarePfmmedical — Medical Imaging Dataset Opportunity
View opportunity →Data Academy
Learn before you deal
- Why Buy External Data?3 min read
- Buying Data Without Mistakes3 min read
- Your Expertise is Gold for AI3 min read